WeChat Mini Program
Old Version Features

USING NON-RANDOMIZED TRIALS TO ASSESS THE CLINICAL BENEFIT OF SYSTEMIC ANTI-CANCER TREATMENTS: VIABLE OR NOT?

N. S. H. Xander,B. Leeneman,A. -M. C. Dingemans,W. E. Fiets,W. K. de Jong, N. E. M. Uyl,A. N. M. Wymenga,A. K. L. Reyners,C. A. Uyl-de Groot

European Journal of Cancer（2024）

Cited 0|Views12
Key words
Randomized controlled trial,Non-randomized trial,Clinical value assessment,Comparison,Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined